GSK-3beta inhibitors (Peking University)

N/A

Report date: 2025/03/20 15:18:18
NME

Base Information

Drug NameGSK-3beta inhibitors (Peking University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycogen synthase kinase-3 beta inhibitors
TargetsGlycogen synthase kinase-3 beta
Therapy Area/IndicationsNerve DegenerationInflammationDiabetes Mellitus +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesPeking University
China Registration ClassN/A

Develop Information

Active CompaniesPeking University
Inactive CompaniesN/A
Active IndicationsNerve DegenerationInflammationDiabetes Mellitus +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A